Novartis claims to have distributed free drugs worth Rs 7,500 cr
The 2005 Patents Act which introduced amendments to the 1970 Act came under severe criticism by the Supreme Court on Wednesday in the Novartis vs Indian Patent Office case. Meanwhile, Novartis filed a...
View ArticleClik here to view.
Judges tell Novartis at Rs 1.2 lakh a month, drugs too expensive for them!
The Supreme Court asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man. A bench of Justices Aftab Alam and Ranajan Prakash Desai...
View ArticleClik here to view.
Generic Drugs – what you need to know
India’s the global leader in the generic market with Indian drugs popular in Africa and other emerging markets. Some Indian pharmaceuticals have even made headway in the USA market. So what are...
View ArticleNausea-free cancer drugs on the cards?
Many drugs that target cancers cause nausea, a common and distressing side-effect with a sensation of unease and discomfort in the upper stomach, say researchers. Now researchers with the help of some...
View ArticleInstrument to aid research in nanoparticles for drug delivery gifted to IIT...
An instrument to accelerate advancement of research in nanoparticles for drug delivery was gifted on Tuesday to a professor from Indian Institute of Technology-Bombay by Izon Science, a New...
View ArticleClik here to view.
India vs Big Pharma: Bayer loses compulsory licencing verdict
Compulsory licences are here to stay. The Intellectual Property Appellate Board (IPAB) on Monday upheld the country’s first compulsory licence to the Hyderabad based NATCO Pharma for Bayer’s cancer...
View ArticleClik here to view.
‘Compulsory licence verdict a triumph for humanity’
In what has been billed as landmark ruling the Intellectual Property Appellate Board upheld the country’s first compulsory licence to NATCO Pharma for Bayer’s cancer drug Nexavar recently. In layman...
View ArticleLeading lawyer calls India’s pharma sector ‘hip and hapenning’
India is a ‘hip and happening country’ when it comes to litigations in the pharmaceutical and biotechnology sectors, said a leading patent attorney said on Thursday. ‘I can definitely say that India is...
View ArticleClik here to view.
India vs Big Pharma: Compulsory licence for leukaemia drug sought
That the compulsory licence verdict in favour of NATCO Pharma would change the landscape of the pharma industries the world over was never in doubt. The verdict was hailed as ‘revolutionary’,...
View ArticleNovartis not optimistic about Supreme Court verdict
It’s a bad time for Big Pharma in India. First the Intellectual Property Appellate Board upheld the first ever compulsory licence handed out to NATCO to sell Bayer’s blockbuster cancer drug Nexavar,...
View ArticleClik here to view.
Free drugs for all?
The government proposes to give away free medicines through government hospitals and health centres. This was announced by Prime Minister Manmohan Singh in his address to the nation on Independence...
View ArticleClik here to view.
How you can prevent cervical cancer
Cervical cancer is known to be spread by a virus called the Human Papilloma Virus (HPV) during sexual contact. We’ve told you about its causes and symptoms, screening including Pap smears. Here are are...
View ArticleClik here to view.
Ten cancer myths debunked
Cancer myths have been around since the disease itself. While being diagnosed with cancer isn’t great news, the disease is by no means inoperable or incurable. There are lots of myths and...
View ArticleClik here to view.
Allow import of new cancer drugs, says expert
India could reap the benefits of new targetted cancer therapy provided its drug control authority allows the import of expensive cancer drugs, an expert said on Sunday. Drugs like Imatinib and...
View ArticleClik here to view.
Now a tag to fight cancer cells in the early stages
A new research has found that it is possible to cut down the growth of cancer cells at their earliest stages with a new drug. Research conducted by leading cancer metabolism researchers at Stony Brook...
View ArticleClik here to view.
Bleomycin, the anticancer drug that works like a pair of scissors
Shedding light on the disease-fighting properties of Bleomycin, used in medications to treat a variety of cancers, a study by an Indian-origin scientist has revealed that the anti-tumour agent has the...
View ArticleClik here to view.
Sun Pharma initiated recall of 200 vials of cancer drug from the US market
A voluntary recall of 200 vials of the cancer drug Gemcitabine injection from the U.S. market was initiated by Sun Pharmaceutical Industries’ US subsidiary Caraco Pharmaceutical Laboratories on April...
View ArticleClik here to view.
Future anti-HIV and cancer drugs to be more cheaper and economical
Researchers have developed an economical, reliable and metal-free chemical reaction that could yield building blocks for future anti-HIV and cancer drugs. A team of researchers from KU Leuven, in...
View ArticleClik here to view.
Can cancer drugs cure malaria?
The US scientists looking for new drugs to fight malaria have identified certain compounds – currently in clinical trials to treat cancer – that could curb drug-resistant malaria strains from...
View ArticleClik here to view.
Generic Drugs – what you need to know
India’s the global leader in the generic market with Indian drugs popular in Africa and other emerging markets. Some Indian pharmaceuticals have even made headway in the USA market. So what are...
View Article